Upgrade to see committee overlap, performance context, and full expert analysis.
BIIB congressional trades
7 matched disclosures
BIIB congressional trades snapshot
This page summarizes public STOCK Act disclosures involving BIIB. It is useful for seeing which lawmakers reported BIIB transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jun 8, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the BIIB congressional trade page shows
Congressional Trader tracks 7 public STOCK Act disclosures for BIIBacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent BIIB filing shown here was filed on Jun 8, 2026 by Maria Elvira Salazar as a purchase. Related lawmakers include Maria Elvira Salazar, Robert P. Bresnahan, Gilbert Ray Cisneros.
Top lawmakers for BIIB
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded BIIB?
Recent BIIB disclosures include Maria Elvira Salazar, Robert P. Bresnahan, Gilbert Ray Cisneros.
What is the buy/sell mix for BIIB?
The visible sample currently shows 6 purchases and 1 sales or partial sales.
Should I trade based on BIIB disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.